You are following this project.
You are already following this project.
You are no longer following this project.
Error occurred in project follow/unfollow action. Please try again.
Project Status: Completed
eMeasure Format Review
At the request of HHS, NQF was asked to convert or retool 113 paper-based measures to an electronic format. The eMeasure Format Review Panel was convened in 2010 to evaluate the structure and intent of the 113 retooled measures.
The panel – made up of a diverse set of healthcare stakeholders – conducted a transparent and thorough review of the measures to fully understand any potential changes in the logic, meaning, or intent in the retooled measures. The panel provided recommendations and guidance on any appropriate actions regarding each measure. The measure stewards were key partners in this process and maintained ultimate approval on all updates completed.
In collaboration with the measure stewards, NQF completed updates to the 113 measures based on the panel’s recommendations, public comments, and measure steward guidance. In December 2011, NQF submitted the full set of 113 retooled measures to HHS with all supporting documentation.
Health IT will convene a body of experts to participate in an ‘eMeasure Format Review Panel’ to conduct a transparent and thorough review of the retooled measures.
The Call for Nominations for panel members closed on March 29, 2010. For information on the Expert Panel formation process, please refer to the Call for Nominations documentation.
Call for Nominations (PDF)
The 14-day review period for submitted nominees closed on May 11, 2010.
Proposed Expert Panel Roster (PDF)
The following final roster reflects input received during the proposed roster review period and the expertise required for the eMeasure expert panel’s scope of work.
Expert Panel Roster (PDF)
Expert Panel Bios (PDF)
The
Review Panel’s Cycle 1 evaluation found no substantive changes to NQF-endorsed
measures that were “retooled,” or converted into an electronic format.
The eMeasure Format Review Panel met via conference call on October 22, 2010 to review Cycle 1 eMeasures.
Agenda (PDF)
Meeting Materials (PDF)
The eMeasure Format Review Panel convened on December 14, 2010 to continue Cycle 1 evaluation.
Agenda (PDF)
Meeting Materials (PDF)
The second cycle of the eMeasure Format Review ended on February 25, 2010. The eMeasure Format Review Panel met on April 25 and April 27 to discuss their comments, public comments, and any substantive changes to the measures.
Each review sought to ensure that, in the process of retooling quality measures, the original intent of the NQF-endorsed measure is sustained.
To evaluate eMeasures for substantive change, NQF sought comments on 1) consistency with endorsed measure logic and 2) appropriate use of Quality Data Model (QDM) elements and accepted value sets.
Resources:
Meeting Minutes, April 25, 2010 (PDF)
Meeting Minutes, April 27, 2010 (PDF)
The following 32 electronic measures were evaluated for substantive change in the second cycle.
eMeasures Reviewed for Format Review Cycle 2 (ZIP)
List of Measures:
NQF #0001 - Asthma Assessment
NQF #0012 - Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
NQF #0013 - Hypertension: Blood Pressure Measurement
NQF #0014 - Prenatal Care: Anti-D Immune Globulin
NQF #0106 - Diagnosis of attention deficit hyperactivity disorder (ADHD) in primary care for school age children and adolescents
NQF #0107 - Management of attention deficit hyperactivity disorder (ADHD) in primary care for school age children and adolescents
NQF #0112 - Bipolar Disorder: Monitoring change in level-of-functioning
NQF #0132 - Aspirin at Arrival
NQF #0137 - ACEI or ARB for LVSD
NQF #0142 - Aspirin Prescribed at Discharge
NQF #0147 - Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients
NQF #0148 - Blood Cultures Performed in the Emergency Department Prior to Initial Antibiotic Received in Hospital
NQF #0151 - Initial Antibiotic Received Within 6 Hours of Hospital Arrival
NQF #0160 - Beta-Blocker Prescribed at Discharge
NQF #0163 - Primary PCI Received Within 90 Minutes of Hospital Arrival
NQF #0164 - Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival
NQF #0298 - Central Line Bundle Compliance
NQF #0300 - Cardiac Surgery Patients With Controlled 6 A.M. Postoperative Blood Glucose
NQF #0302 - Ventilator Bundle
NQF #0329 - All Cause Readmission Index (risk adjusted)
NQF #0356 - Blood Cultures Performed Within 24 Hours Prior to or 24 Hours After Hospital Arrival for Patients Who Were Transferred or Admitted to the ICU Within 24 Hours of Hospital Arrival
NQF #0416 - Diabetic Foot and Ankle Care, Ulcer Prevention - Evaluation of Footwear
NQF #0453 - Urinary catheter removed on Postoperative Day 1 (POD 1) or Postoperative Day 2 (POD 2) with day of surgery being day zero
NQF #0471 - Cesarean Rate for Low-Risk Birth Women
NQF #0484 - Proportion of Infants 22 to 29 Weeks Gestation Treated with Surfactant who are Treated within 2 Hours of Birth
NQF #0496 - Median Time from ED Arrival to ED Departure for Discharged ED Patients
NQF #0527 - Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision
NQF #0528 - Prophylactic Antibiotic Selection for Surgical Patients
NQF #0529 - Prophylactic Antibiotics Discontinued Within 24 Hours After Surgery End Time
NQF #OT3-011-10 - Depression Remission at Twelve Months
NQF #OT3-012-10 - Depression Remission at Six Months
NQF #OT3-022-10 - Depression Utilization of the PHQ-9 Tool
The third cycle of the eMeasure Format Review ended on April 1, 2010. The eMeasure Format Review Panel met on May 23 and May 24 to discuss their comments, public comments, and any substantive changes to the measures.
Each review sought to ensure that, in the process of retooling quality measures, the original intent of the NQF-endorsed measure is sustained.
To evaluate eMeasures for substantive change, NQF sought comments on 1) consistency with endorsed measure logic and 2) appropriate use of Quality Data Model (QDM) elements and accepted value sets.
Resources:
Meeting Minutes, May 23, 2010 (PDF)
Meeting Minutes, May 24, 2010 (PDF)
The following 32 electronic measures were evaluated for substantive change in the second cycle.
eMeasures Reviewed for Cycle 3 (ZIP)
List of eMeasures:
NQF #0002 - Appropriate Testing for Children with Pharyngitis
NQF #0004 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement
NQF #0022 - Drugs to be avoided in the elderly: a. Patients who receive at least one drug to be avoided, b. Patients who receive at least two different drugs to be avoided
NQF #0024 - Weight Assessment and Counseling for Children and Adolescents
NQF #0032 - Cervical Cancer Screening
NQF #0033 - Chlamydia Screening for Women
NQF #0036 - Use of Appropriate Medications for Asthma
NQF #0041 - Preventive Care and Screening: Influenza Immunization for Patients >= 50 Years Old
NQF #0047 - Asthma Pharmacologic Therapy
NQF #0051 - Osteoarthritis: assessment for use of anti-inflammatory or analgesic over-the-counter (OTC) medications
NQF #0066 - Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Patients with CAD and Diabetes and/or Left Ventricular Systolic Dysfunction (LVSD)
NQF #0067 - Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
NQF #0074 - Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol
NQF #0083 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
NQF #0084 - Heart Failure (HF) : Warfarin Therapy Patients with Atrial Fibrillation
NQF #0086 - Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
NQF #0088 - Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
NQF #0089 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
NQF #0102 - Chronic Obstructive Pulmonary Disease (COPD): Bronchodilator Therapy
NQF #0103 - Major Depressive Disorder (MDD): Diagnostic Evaluation
NQF #0104 - Major Depressive Disorder (MDD): Suicide Risk Assessment
NQF #0138 - Urinary catheter-associated urinary tract infection for intensive care unit (ICU) patients
NQF #0139 - Central line catheter-associated blood stream infection rate for ICU and high-risk nursery (HRN) patients
NQF #0239 - Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (when indicated in ALL patients)
NQF #0241 - Stroke and Stroke Rehabilitation: Anticoagulant Therapy Prescribed for Atrial Fibrillation at Discharge
NQF #0341 - PICU Pain Assessment
NQF #0342 - PICU Periodic Pain Assessment
NQF #0348 - Iatrogenic Pneumothorax in Non-Neonates (risk adjusted) (PDI5)
NQF #0362 - Foreign Body left after procedure (PDI3)
NQF #0513 - Use of Contrast: Thorax CT
NQF #0519 - Diabetic Foot Care and Patient/Caregiver Education Implemented During Short Term Episodes of Care
NQF #0608 - Pregnant women that had HBsAg testing
The fourth and final cycle of the eMeasure Format Review ended on May 2 2010. The eMeasure Format Review Panel met on June 24 and June 30 to discuss their comments, public comments, and any substantive changes to the measures.
Each review sought to ensure that, in the process of retooling quality measures, the original intent of the NQF-endorsed measure is sustained.
To evaluate eMeasures for substantive change, NQF sought comments on 1) consistency with endorsed measure logic and 2) appropriate use of Quality Data Model (QDM) elements and accepted value sets.
Resources:
Meeting Minutes, June 24, 2010 (PDF)
Meeting Minutes, June 30, 2010 (PDF)
The following 33 electronic measures were evaluated for substantive change in the second cycle.
eMeasure Format Review Cycle 4 (ZIP)
List of eMeasures
NQF #0038 - Childhood immunization Status
NQF #0045 - Osteoporosis: Communication with the Physician Managing Ongoing Care Post-Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older
NQF #0046 - Osteoporosis: Communication with the Physician Managing Ongoing Care Post-Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older
NQF #0048 - Osteoporosis: Management Following Fracture of Hip, Spine or Distal radius for Men and Women Aged 50 Years and Older
NQF #0049 - Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older
NQF #0052 - Low Back Pain: Use of Imaging Studies
NQF #0055 - Diabetes: Eye Exam
NQF #0056 - Diabetes: Foot Exam
NQF #0060 - Hemoglobin A1c Test for Pediatric Patients
NQF #0062 - Diabetes: Urine Screening
NQF #0069 - Treatment for Children with Upper Respiratory Infection (URI): Avoidance of Inappropriate Use
NQF #0073 - Ischemic Vascular Disease (IVD): Blood Pressure Management
NQF #0097 - Medication Reconciliation
NQF #0105 - Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b)Effective Continuation Phase Treatment
NQF #0108 - ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
NQF #0246 - Stroke and Stroke Rehabilitation: Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) Reports
NQF #0268 - Perioperative Care: Selection of Prophylactic Antibiotic - First OR Second Generation Cephalosporin
NQF #0270 - Perioperative Care: Timing of Prophylactic Antibiotics - Ordering Physician
NQF #0271 - Perioperative Care: Discontinuation of Prophylactic Antibiotics (Non-Cardiac Procedures)
NQF #0321 - End Stage Renal Disease (ESRD): Plan of Care for Inadequate Peritoneal Dialysis
NQF #0323 - End Stage Renal Disease (ESRD): Plan of Care of Inadequate Hemodialysis in ESRD Patients
NQF #0385 - Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
NQF #0387 - Hepatitis C: Antiviral Treatment Prescribed
NQF #0389 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
NQF #0397 - Hepatitis C: Antiviral Treatment Prescribed
NQF #0399 - Hepatitis C: Hepatitis A Vaccination in Patients with HCV
NQF #0400 - Hepatitis C: Hepatitis B Vaccination in Patients with HCV
NQF #0401 - Hepatitis C: Counseling Regarding Risk of Alcohol Consumption
NQF #0507 - Stenosis Measurement in Carotid Imaging Studies
NQF #0508 - Radiology: Inappropriate Use of "Probably Benign" Assessment Category in Mammography Screening
NQF #0510 - Radiology: Exposure Time Reported for Procedures Using Fluoroscopy
NQF #ACP-017-10 - Endoscopy & Polyp Surveillance: Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate Use
